MOLECULAR INSIGHTS IN ANTI-TUMOR ACTIVITIES OF HDAC INHIBITORS IN MOUSE MODELS OF ACUTE MYELOGENOUS LEUKEMIA (AML)

  • Überblick


    Datum: 24.08.2010, 12:00

    Veranstaltungsort

    HZI, Room A.1.05

    Referent

    Dr. Michael Bots (Peter McCallum Cancer Research Center, Melbourne,Australia/ AMC Medical Center Amsterdam)

    Gastgeber

    Helmholtz Centre for Infection Reserach, Prof. Dr. Lars Zender